Promising Celiac Disease Drug KAN-101 Proves Safe and Tolerable in Phase 1 Testing

Welcome to Celiac.com!

You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.
Celiac.com Sponsor (A1):

Celiac.com Sponsor (A1-M):
Get Celiac.com Updates:

Support Our Content

eNewsletter

Donate
By Jefferson Adams

August 17, 2023
By Jefferson Adams • August 17, 2023

Promising Celiac Disease Drug KAN-101 Proves Safe and Tolerable in Phase 1 Testing

Followers 2
Reviewed and edited by a celiac disease expert.

Early-stage data support KAN-101, a liver-targeting drug that's vying to become the first treatment approved to treat celiac disease. But a long road awaits.

Caption: Image: CC BY 2.0--j9sk9s

Celiac.com 08/17/2023 - KAN-101, the most recent drug designed to induce immune tolerance to wheat gluten, has proven safe and tolerable in the Phase 1 stage of testing. Now the hard work starts.

The drug has shown promise for treating celiac disease, an autoimmune condition where the body reacts negatively to gluten in the small intestines. The drug, developed by Anokion, targets the liver to promote immune tolerance to gluten in people with celiac disease.

KAN-101 Demonstrated Safety and Pharmacokinetic Potential

Celiac.com Sponsor (A12):
In the first-in-human phase 1 ACeD trial, KAN-101 demonstrated safety and pharmacokinetic potential. The trial involved 41 adult patients with biopsy-confirmed celiac disease, all with the HLA-DQ2.5 genotype, which is associated with celiac disease. The patients received different doses of KAN-101 through intravenous administration.

No Serious Adverse Events or Dose-limiting Toxicities

Results showed that the drug had acceptable safety, with no serious adverse events or dose-limiting toxicities. Common mild to moderate side effects included nausea, diarrhea, abdominal pain, and vomiting, which were consistent with celiac disease symptoms. KAN-101 rapidly cleared from the patients' systems within approximately 6 hours, and there was no accumulation on repeated dosing.

Deborah Geraghty, CEO of Anokion, expressed excitement about the drug's potential to induce immune tolerance to gluten, providing a durable treatment effect for celiac disease patients. With celiac disease currently lacking an FDA-approved treatment option, KAN-101 could be a game-changer.

The research team plans to further analyze KAN-101's efficacy and safety in human patients, particularly with biomarker responses from a gluten challenge, at doses of 0.6 mg/kg or higher in those with celiac disease.

If successful, KAN-101 could significantly impact the lives of those with celiac disease by providing a viable and effective treatment option.

While the early testing is encouraging, it's a long haul from Phase 1 to full approval, and so far, no drug designed to treat celiac disease has made the journey. The failures are legion. So, celiac sufferers should take this news with a grain of salt.

Read more at HCPlive.com
celiac disease

drug

kan-101

safe

treatment

trial
Share
Followers 2
Go to articles
User Feedback
- 1 Comment
Recommended Comments

Oldturdle 31

Posted August 17, 2023

Share this comment

My liver anxiously awaits!

Link to comment

Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!
Register a new account

Sign in

Already have an account? Sign in here.
Sign In Now
Get Celiac.com Updates:

Support Celiac.com:

Join eNewsletter

Donate
About Me

Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University. His articles, essays, poems, stories and book reviews have appeared in numerous magazines, journals, and websites, including North American Project, Antioch Review, Caliban, Mississippi Review, Slate, and more. He is the author of more than 2,500 articles on celiac disease. His university coursework includes studies in science, scientific methodology, biology, anatomy, physiology, medicine, logic, and advanced research. He previously devised health and medical content for Colgate, Dove, Pfizer, Sharecare, Walgreens, and more. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of numerous books, including "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

>VIEW ALL ARTICLES BY JEFFERSON ADAMS
Celiac.com Sponsor (A17):

Celiac.com Sponsor (A17):

Celiac.com Sponsors (A17-M):
Related Articles
Why All the Hate for Celiac Disease Drug Treatments?
Celiac.com 09/18/2015 - That old saw about death and taxes might need a bit of amending to include complaints about pharmaceutical companies working on celiac drug treatments.
One interesting facet of our coverage of the development of various drugs to treat and/or cure celiac disease has been the regular presence of comments questioning the motives,and actions of the companies involved.
It's funny, but no one complains that companies still make money selling aspirin, and that no one has cured a headache, and that there must be some conspiracy to profit off of those who suffer a headache.
There's no doubt that there's money to be made producing drugs that treat disease. But, if a company can develop and produce a safe drug to protect celiacs against contamination,...

Read Full Article...

34 comments

11,369 views
FDA Issues New Guidelines for Celiac Drug Trials
Celiac.com 07/04/2022 - The Food and Drug Administration (FDA) has issued a set of new guidelines for companies doing celiac disease drug trials. The agency noted that the guidance is intended only to provide clarity regarding existing requirements, and should be viewed solely as recommendations, unless they mention specific regulations or laws.
The FDA directs sponsors of trials for clinical drugs to ensure the following regarding celiac disease patients on a gluten-free diet:
Trial population
Patients should undergo diagnostic esophagogastroduodenoscopy, with multiple biopsies to confirm celiac diagnosis. The biopsies should include one or two samples of the duodenal bulb and at least four samples of the distal duodenum.
To avoid inclusion of patients whose ...

Read Full Article...

0 comments

2,647 views
Celiac Disease Drug KAN-101 Gets FDA Fast Track
Celiac.com 07/26/2022 - Previous drugs designed to induce tolerance to gliadin have met with failure. Will the latest effort fare any better?
In people with celiac disease, gliadin-specific T cells drive an adverse immune response to gluten peptides, which can cause symptoms, long-term gut damage, and other related conditions. Currently, the only treatment for celiac disease is a gluten-free diet.
A new drug, KAN-101, designed to treat celiac disease by inhibiting a key celiac disease biomarker, has received fast track status from the FDA ahead of Phase 2 Trials slated for the second half 2022. Designed by Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, KAN-101 has been found to be safe, well-to...

Read Full Article...

5 comments

10,458 views
Are Celiac Disease Drug Treatments Just a Pipe Dream?
Celiac.com 09/21/2022 - The dream of creating a safe, effective drug that can help people with celiac disease to tolerate small amounts, or perhaps even large amounts, of gluten. Until its recent failure, 9 Meters' larazotide was the only celiac drug in Phase 3 clinical trials. The recent discontinuation of larazotide, based on disappointing interim results, highlights the unmet need for effective alternatives to a gluten-free diet for treating celiac disease.
Larazotide's failure also opens the doors for current and future Phase 1 and Phase 2 celiac therapies to be first-to-market. It also highlights the lack of a good lineup of potential new drugs. The reality is that, with the collapse of several once promising candidates, the bench for viable alternative celiac disease treatments ...

Read Full Article...

32 comments

16,216 views
Recent Activity
1. 1 hour ago - Scott Adams replied to Patrick-Tyler's topic in Gluten-Free Restaurants
  5
  
  Is McDonald's Safe for Gluten-Free Orders?
  
  Hydrolyzed wheat is wheat protein that has been broken down into smaller components through a chemical or enzymatic process called hydrolysis. This ingredient can be found in various products, including cosmetics, personal care items, and some food products. For people with celiac disease, hydrolyzed wheat is generally not safe to consume because it...
2. 1 hour ago - trents replied to Patrick-Tyler's topic in Gluten-Free Restaurants
  5
  Is McDonald's Safe for Gluten-Free Orders?
  
  Here is an excerpt from this article: https://pmc.ncbi.nlm.nih.gov/articles/PMC82695: Studies have shown that various peptidases of fungal, plant, animal, or bacterial origin are able to hydrolyze gluten into harmless peptides. According to SDS‐PAGE pattern, proteolytic enzymes hydrolyze gliadins (Heredia‐Sandoval et al., 2016; Scherf et al., 2...
  
  1
3. 1 hour ago - Scott Adams replied to GeordieGeezer's topic in Food Intolerance & Leaky Gut
  17
  
  Anybody else have a similar experience...theories welcome as its something which i dont really understand.....
  
  There aren't good studies that have been done on celiac disease remission, and I'm going from a distant memory of an older post here, but the longest remission that Dr. Stefano Guandalini from the University of Chicago Celiac Disease Center has witnessed was ~10 years, then the symptoms of celiac disease and the damage came back. The real issue though, is...
4. 1 hour ago - trents replied to Patrick-Tyler's topic in Gluten-Free Restaurants
  5
  
  Is McDonald's Safe for Gluten-Free Orders?
  
  Scott, could you elaborate on hydrolyzed wheat? Does that remove or deactivate the gluten protein?
5. 1 hour ago - Scott Adams replied to Patrick-Tyler's topic in Gluten-Free Restaurants
  5
  
  Is McDonald's Safe for Gluten-Free Orders?
  
  McDonald's has a gluten-free bun, are you in Europe? They don't have that in the USA but I hope they are coming here soon. In the USA the fries are not considered gluten-free, even if they are made in a dedicated fryer, but many celiacs, including myself, have been eating them for years without issues. In Europe they don't have the same hydrolyzed wheat...